Non‐alcoholic fatty liver disease from pathogenesis to management: an update
Summary Non‐alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the Western world, is tightly associated with obesity and metabolic syndrome. NAFLD entails an increased cardiometabolic and liver‐related risk, the latter regarding almost exclusively non‐alcoholic steatohep...
Uloženo v:
Hlavní autoři: | Giovanni Musso, Roberto Gambino, Maurizio Cassader |
---|---|
Médium: | Revisão |
Jazyk: | angličtina |
Vydáno: |
2009
|
On-line přístup: | https://doi.org/10.1111/j.1467-789x.2009.00657.x |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
Autor: Giovanni Musso, a další
Vydáno: (2012) -
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
Autor: Giovanni Musso, a další
Vydáno: (2012) -
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Autor: Giovanni Musso, a další
Vydáno: (2010) -
PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease
Autor: Giovanni Musso, a další
Vydáno: (2014) -
A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
Autor: Giovanni Musso, a další
Vydáno: (2010)